myositis |
Disease ID | 177 |
---|---|
Disease | myositis |
Manually Symptom | UMLS | Name(Total Manually Symptoms:20) C2707258 | infections C2697391 | rheumatoid arthritis C1962971 | myocarditis C0748159 | pulmonary involvement C0746787 | neck cancer C0741885 | occult malignancy C0410000 | overlap syndrome C0206062 | interstitial lung disease C0162323 | polyarthritis C0152025 | polyneuropathy C0085434 | bacillary angiomatosis C0038013 | ankylosing spondylitis C0035435 | rheumatic diseases C0034372 | quadriplegia C0027121 | muscle inflammation C0026896 | myasthenia gravis C0011849 | diabetes mellitus C0011168 | dysphagia C0009782 | connective tissue disorder C0006663 | calcinosis |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:7) C0410000 | overlap syndrome | 5 C0206062 | interstitial lung disease | 4 C0003873 | rheumatoid arthritis | 4 C0011168 | dysphagia | 2 C0027059 | myocarditis | 2 C0021311 | infections | 1 C0027121 | muscle inflammation | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:17) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0027121 | carbamazepine | D002220 | 298-46-4 | myositis | MESH:D009220 | marker/mechanism | 8293614 | ||
C0027121 | carbimazole | D002231 | 22232-54-8 | myositis | MESH:D009220 | marker/mechanism | 1681385 | ||
C0027121 | cisplatin | D002945 | 15663-27-1 | myositis | MESH:D009220 | marker/mechanism | 10398795 | ||
C0027121 | fluoxetine | D005473 | 54910-89-3 | myositis | MESH:D009220 | marker/mechanism | 10868505 | ||
C0027121 | griseofulvin | D006118 | 126-07-8 | myositis | MESH:D009220 | marker/mechanism | 7572547 | ||
C0027121 | hydroxyurea | D006918 | 127-07-1 | myositis | MESH:D009220 | marker/mechanism | 12894095 | ||
C0027121 | leuprolide | D016729 | 53714-56-0 | myositis | MESH:D009220 | marker/mechanism | 1954704 | ||
C0027121 | lidocaine | D008012 | 137-58-6 | myositis | MESH:D009220 | marker/mechanism | 736396 | ||
C0027121 | lovastatin | D008148 | 75330-75-5 | myositis | MESH:D009220 | marker/mechanism | 16089017 | ||
C0027121 | metformin | D008687 | 657-24-9 | myositis | MESH:D009220 | marker/mechanism | 11062950 | ||
C0027121 | phenytoin | D010672 | 57-41-0 | myositis | MESH:D009220 | marker/mechanism | 1036571 | ||
C0027121 | pravastatin | D017035 | 81093-37-0 | myositis | MESH:D009220 | marker/mechanism | 12528328 | ||
C0027121 | progesterone | D011374 | 57-83-0 | myositis | MESH:D009220 | marker/mechanism | 3342908 | ||
C0027121 | propylthiouracil | D011441 | 51-52-5 | myositis | MESH:D009220 | marker/mechanism | 566489 | ||
C0027121 | tacrolimus | D016559 | 109581-93-3 | myositis | MESH:D009220 | marker/mechanism | 15110639 | ||
C0027121 | tretinoin | D014212 | 302-79-4 | myositis | MESH:D009220 | marker/mechanism | 10629576 | ||
C0027121 | troglitazone | C057693 | 97322-87-7 | myositis | MESH:D009220 | marker/mechanism | 11281188 |
FDA approved drug and dosage information(Total Drugs:1) | ||||||||
---|---|---|---|---|---|---|---|---|
DiseaseID | Drug_name | active_ingredients | strength | Dosage Form/Route | Marketing Status | TE code | RLD | RS |
MESH:D009220 | mevacor | lovastatin | 10MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons | TABLET;ORAL | Discontinued | None | Yes | No |
FDA labeling changes(Total Drugs:1) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DiseaseID | Pediatric_Labeling_Date | Trade_Name | Generic_Name_or_Proper_Name | Indications Studied | Label Changes Summary | Product Labeling | BPCA(B) | PREA(P) | BPCA(B) and PREA(P) | Pediatric Rule (R) | Sponsor | Pediatric Exclusivity Granted Date | NNPS |
MESH:D009220 | 02/14/2002 | mevacor | lovastatin | Heterozygous Familial Hypercholesterolemia | New indication in adolescent boys and girls (at least one year post-menarche) 10-17 years of age | Labeling | B | - | - | - | Merck | 07/17/2001 | FALSE' |